Skip to main content

U-PGx

Ubiquitous Pharmacogenomics (U-PGx)

The “Ubiquitous Pharmacogenomics” project (U-PGx) to establish a firm foundation for ‘Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen’.


The European Union H2020 programme has awarded a €15 million grant to the Ubiquitous Pharmacogenomics (U-PGx) consortium. The Medical University of Vienna plays a key role in the project, which will implement pharmacogenomic testing and computer-based decision support for 8,000 patients in 7 European countries to investigate whether this emerging approach is cost-effective and results in better patient outcomes.


MedUni Vienna Researchers

Assoc.-Prof. Dr. Matthias Samwald

Center for Medical Statistics, Informatics and Intelligent Systems
Section for Artificial Intelligence and Decision Support
matthias.samwald@meduniwien.ac.at

Research Staff

Dr. Kathrin Blagec

Project Team Members

Ao. Univ.-Prof. Dr. Gere Sunder-Plassmann
Ao. Univ. Prof. Dr. Alice Schmidt
Assoz. Prof. Dr. Gürkan Sengoelge
Department of Medicine III, Division of Nephrology and Dialysis


Consortium

16 project participants
Coordinator:  Prof. Dr. Henk-Jan Guchelaar, Leiden University Medical Center, the Netherlands


Facts

ProgrammeH2020
Call/TopicPHC-24-2015: Piloting personalised medicine in health and care systems
Project duration 01.01.2016 - 31.12.2020
EU contribution – MedUni Vienna € 1.429.783
EC contribution – total project

 € 14.936.613